Search
for
Sort by
Research 331–360 of 1000+
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Epidemiological characteristics of the COVID-19 outbreak in a secondary hospital in Spain
- COVID-19 infection is a major cause of acute telogen effluvium
- Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
- Symptom Trajectories and Long-Term Sequelae of COVID-19: A Matched Case–Control Study with Population-Based Controls
- Factors Associated with Acute Telogen Effluvium and COVID-19 Infection
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- CARACTERÍSTICAS CLÍNICAS DO EFLÚVIO TELÓGENO INDUZIDO PELA INFECÇÃO DE COVID-19: REVISÃO INTEGRATIVA
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Commonalities Between COVID-19 and Radiation Injury
- International collaboration and rapid harmonization across dermatologic COVID-19 registries
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- A case study of homoeopathic management of stress-induced alopecia totalis
- Management of telogen effluvium during the COVID‐19 emergency: Psychological implications
- Dermatologia Capilar: Fisiologia do Folículo Piloso e Principais Afecções
- Long- COVID and general health status in hospitalized COVID-19 survivors
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia